Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2025-12-25 @ 4:11 AM
NCT ID:
NCT02080520
Eligibility Criteria:
Inclusion Criteria:
* Age \>55 years
* Male or postmenopausal female (no uterine bleeding for \>6 months)
Exclusion Criteria:
* Clinical signs, symptoms, or personal history of cardiovascular disease
* Diabetes mellitus or fasting serum glucose \>140 mg/dL
* Plasma triglyceride levels \>500 mg/dL
* Uncontrolled hypertension (systolic blood pressure \>160 mmHg or diastolic blood pressure \>110 mmHg)
* Uncontrolled tachycardia or irregular heart rates (i.e., atrial fibrillation)
* Thyroid disease (untreated)
* Renal insufficiency (defined as serum creatinine \>2.0 mg/dL)
* Life threatening illness with prognosis \<5 years
* Current use of lipid-lowering medication
* Current use of food supplements containing soy, soy protein, isoflavones or other phytoestrogens
* Known sensitivity or allergy to soy or nuts
* Regular aspirin or other antiplatelet medication use
* Use of anticoagulants
* Bleeding diatheses or tendencies
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
55 Years
Maximum Age:
100 Years
Study:
NCT02080520
Study Brief:
Protocol Section:
NCT02080520